News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

AcronGenomics Inc. (AGNM) and Molecular Vision Ltd.: Fully Functional Multi-Channel Prototype Device Undergoing Internal Validation



4/9/2008 1:15:27 PM

GENEVA--(BUSINESS WIRE)--Acrongenomics Inc. (AGNM: OTCBB), today announces that it is fully committed to the joint collaboration contract in partnership with Molecular Vision.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES